Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease.
作者信息
Rubin David T, Sohi Sunana, Shilling Rebecca A, White Steven R
机构信息
Section of Gastroenterology.
Section of Pulmonary and Critical Care, University of Chicago, Chicago, Ill.
出版信息
Gastroenterol Hepatol (N Y). 2006 Aug;2(8):592-596.
Abstract
摘要
相似文献
1
Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease.英夫利昔单抗治疗克罗恩病后出现的肺部嗜酸性粒细胞增多症。
Gastroenterol Hepatol (N Y). 2006 Aug;2(8):592-596.
2
Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experience.英夫利昔单抗引入后克罗恩病的治疗费用：单中心英国经验。
Aliment Pharmacol Ther. 2010 Dec;32(11-12):1357-63. doi: 10.1111/j.1365-2036.2010.04482.x. Epub 2010 Oct 7.
3
A Case of Breast Cancer Following Infliximab Treatment for Treatment-Refractory Crohn's Disease.英夫利昔单抗治疗难治性克罗恩病后发生乳腺癌1例
Euroasian J Hepatogastroenterol. 2014 Jul-Dec;4(2):104-106. doi: 10.5005/jp-journals-10018-1112. Epub 2014 Jul 28.
4
A rare case of free bowel perforation associated with infliximab treatment for stricturing Crohn's disease.1例罕见的与英夫利昔单抗治疗狭窄型克罗恩病相关的游离性肠穿孔病例。
Korean J Gastroenterol. 2013 Sep;62(3):169-73. doi: 10.4166/kjg.2013.62.3.169.
6
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.英夫利昔单抗：关于其在克罗恩病和类风湿性关节炎中应用的最新综述
BioDrugs. 2002;16(2):111-48. doi: 10.2165/00063030-200216020-00005.
7
Infliximab in treatment of Crohn's disease: the Milan experience.英夫利昔单抗治疗克罗恩病：米兰经验
Dig Liver Dis. 2002 Jun;34(6):411-8. doi: 10.1016/s1590-8658(02)80038-x.
8
Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy? The Infliximab User Group.澳大利亚早期使用英夫利昔单抗（一种抗肿瘤坏死因子-α的嵌合抗体）治疗克罗恩病的经验：类固醇节省免疫抑制疗法能否增强其疗效？英夫利昔单抗用户组
Intern Med J. 2001 Apr;31(3):146-50. doi: 10.1046/j.1445-5994.2001.00039.x.
9
Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.英夫利昔单抗和其他抗肿瘤坏死因子 α 治疗药物治疗炎症性肠病。
BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000.
10
The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.术前英夫利昔单抗治疗克罗恩病患者行腹部手术后术后并发症的风险：系统评价和荟萃分析。
J Crohns Colitis. 2013 Dec;7(11):868-77. doi: 10.1016/j.crohns.2013.01.019. Epub 2013 Mar 5.
引用本文的文献
1
TNF-alpha Inhibitors Induced Eosinophilia: A Case Report of an Undervalued Side Effect of Such Biologicals.肿瘤坏死因子-α抑制剂诱导的嗜酸性粒细胞增多症：此类生物制剂一种被低估的副作用的病例报告
Endocr Metab Immune Disord Drug Targets. 2025;25(6):503-507. doi: 10.2174/0118715303309437240703114340.
2
Eosinophilic pulmonary disease with ulcerative colitis: A case report.嗜酸粒细胞性肺病合并溃疡性结肠炎：一例报告。
Medicine (Baltimore). 2024 Apr 26;103(17):e37851. doi: 10.1097/MD.0000000000037851.
3
Lessons of the month 2: Chronic eosinophilic pneumonia (CEP): A rare manifestation of infliximab therapy.本月病例2：慢性嗜酸性粒细胞性肺炎（CEP）：英夫利昔单抗治疗的罕见表现
Clin Med (Lond). 2020 Jul;20(4):435-437. doi: 10.7861/clinmed.2020-0271.
4
Review.综述
Gastroenterol Hepatol (N Y). 2006 Aug;2(8):597.
本文引用的文献
1
Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease.英夫利昔单抗用于治疗转移性肝和肺克罗恩病。
Inflamm Bowel Dis. 2005 Feb;11(2):210-2. doi: 10.1097/00054725-200502000-00020.
2
Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease.英夫利昔单抗治疗克罗恩病后出现弥漫性肺泡出血。
Inflamm Bowel Dis. 2004 May;10(3):274-7. doi: 10.1097/00054725-200405000-00016.
3
Noninfectious lung pathology in patients with Crohn's disease.克罗恩病患者的非感染性肺部病理
Am J Surg Pathol. 2003 Feb;27(2):213-9. doi: 10.1097/00000478-200302000-00010.
4
Churg-Strauss syndrome in two patients receiving montelukast.两名服用孟鲁司特的患者出现了变应性肉芽肿性血管炎。
Rheumatology (Oxford). 2002 May;41(5):535-9. doi: 10.1093/rheumatology/41.5.535.
5
Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusion.英夫利昔单抗输注后迟发型超敏反应和急性呼吸窘迫综合征
Inflamm Bowel Dis. 2002 May;8(3):186-91. doi: 10.1097/00054725-200205000-00005.
6
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.与英夫利昔单抗（一种肿瘤坏死因子α中和剂）相关的结核病。
N Engl J Med. 2001 Oct 11;345(15):1098-104. doi: 10.1056/NEJMoa011110.
7
Crohn's disease involving the lung: resolution with infliximab.
Dig Dis Sci. 2001 Aug;46(8):1736-9. doi: 10.1023/a:1010665807294.
8
The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report.哮喘治疗与变应性肉芽肿性血管炎的关系：美国国立卫生研究院研讨会总结报告
J Allergy Clin Immunol. 2001 Aug;108(2):175-83. doi: 10.1067/mai.2001.117176.
9
Invasive pulmonary aspergillosis associated with infliximab therapy.英夫利昔单抗治疗相关的侵袭性肺曲霉病。
N Engl J Med. 2001 Apr 5;344(14):1099-100.
10
Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.接受孟鲁司特治疗哮喘的患者中的变应性肉芽肿性血管炎。
Chest. 2000 Mar;117(3):708-13. doi: 10.1378/chest.117.3.708.
Zotero 插件